Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | HSPA8 | P11142 | 3/20 | 0.66 |
| ▸ | SLC28A2 | O43868 | 3/20 | 0.66 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.64 |
| ▸ | PRKACA | P17612 | 1/20 | 0.61 |
| ▸ | PRKACG | P22612 | 1/20 | 0.61 |
| ▸ | PRKACB | P22694 | 1/20 | 0.61 |
| ▸ | PDE4A | P27815 | 1/20 | 0.61 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.61 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.61 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.61 |
| ▸ | GAPDH | P04406 | 2/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | HBB | P68871 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL578218 | 1.00 | CYP3A4 (0.67) | CYP3A4MAPTHSPA8SLC28A2HSPA5 | |
| SCHEMBL30316415 | 1.00 | CYP3A4 (0.67) | CYP3A4MAPTHSPA8SLC28A2HSPA5 | |
| SCHEMBL7258957 | 0.90 | HSPA8 (0.66) | CYP3A4MAPTHSPA8SLC28A2HSPA5 | |
| SCHEMBL7258948 | 0.90 | HSPA8 (0.66) | CYP3A4MAPTHSPA8SLC28A2HSPA5 | |
| SCHEMBL13835110 | 0.90 | GAPDH (0.70) | HSPA8SLC28A2HSPA5PDE4APDE4B | |
| SCHEMBL13835106 | 0.90 | GAPDH (0.70) | HSPA8SLC28A2HSPA5PDE4APDE4B | |
| SCHEMBL5328057 | 0.89 | RAPGEF3 (0.61) | CYP3A4MAPTHSPA8SLC28A2HSPA5 | |
| SCHEMBL30237368 | 0.89 | RAPGEF3 (0.61) | CYP3A4MAPTHSPA8SLC28A2HSPA5 | |
| SCHEMBL5328067 | 0.89 | RAPGEF3 (0.61) | CYP3A4MAPTHSPA8SLC28A2HSPA5 | |
| SCHEMBL13834974 | 0.88 | SLC28A2 (0.68) | HSPA8SLC28A2HSPA5PDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008153881-A1 | NOVEL CELL-BASED ASSAYS FOR INDENTIFYING ENHANCERS OR INHIBITORS OF T1R TASTE RECEPTORS (T1R2/T1R3 SWEET) AND UMAMI (T1R1/T1R3 UMAMI) TASTE RECEPTORS | SENOMYX, INC. (US) | 2008-12-18 | — | — | WO | claimed |
| WO-2007149554-A2 | METHODS FOR RESTORING NEURAL FUNCTION | THE JOHNS HOPKINS UNIVERSITY (US) | 2007-12-27 | — | — | WO | claimed |
| US-20230129380-A1 | Method for Estimating Molecular Complexity | CHEMIFY LIMITED (GB) | 2023-04-27 | — | — | US | disclosed |
| EP-2707483-B1 | METHODS AND MATERIALS FOR NUCLEIC ACID MANIPULATION | RWTH AACHEN UNIV (DE) | 2017-10-18 | — | — | EP | disclosed |
| WO-2015193378-A1 | NOVEL GLP-1 RECEPTOR AGONISTS WITH CHOLESTEROL EFFLUX ACTIVITY | NOVO NORDISK A/S (DK) | 2015-12-23 | — | — | WO | disclosed |
| EP-2935318-A1 | NOVEL GLP-1 RECEPTOR AGONISTS WITH CHOLESTEROL EFFLUX ACTIVITY | Novo Nordisk A/S (DK) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014096179-A1 | NOVEL GLP-1 RECEPTOR AGONISTS WITH CHOLESTEROL EFFLUX ACTIVITY | NOVO NORDISK A/S (DK) | 2014-06-26 | — | — | WO | disclosed |
| US-20120295311-A1 | Methods and Materials for Nucleic Acid Manipulation | BASF SE (DE) | 2012-11-22 | — | — | US | disclosed |
| US-20100029561-A1 | AMELIORATING AGENT FOR INSULIN RESISTANCE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-2123303-A1 | AMELIORATING AGENT FOR INSULIN RESISTANCE | Takeda Pharmaceutical Company Limited (JP) | 2009-11-25 | — | — | EP | disclosed |
| WO-2007149554-A2 | METHODS FOR RESTORING NEURAL FUNCTION | THE JOHNS HOPKINS UNIVERSITY (US) | 2007-12-27 | — | — | WO | disclosed |
| US-6372500-B1 | FOR TRANSFECTION OF EPITHELIAL TISSUE WITH THE CASSETTES IN THERAPY OF CYSTIC FIBROSIS, EMPHYSEMA, CANCERS OF EPITHELIAL ORIGIN ARISING IN THE LUNG OR OTHER ORGANS | HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) | 2002-04-16 | — | — | US | disclosed |
| EP-1080186-A2 | METHOD FOR ALTERING THE ACTIVITY OF PROTEINS OF THE PKA SIGNALING PATHWAY | Lauras AS (NO) | 2001-03-07 | — | — | EP | disclosed |
| WO-1999062315-A2 | METHOD FOR ALTERING THE ACTIVITY OF PROTEINS OF THE PKA SIGNALING PATHWAY | LAURAS AS (NO) | 1999-12-02 | — | — | WO | disclosed |
| WO-1998051807-A1 | EPISOMAL EXPRESSION CASSETTES FOR GENE THERAPY | HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) | 1998-11-19 | — | — | WO | disclosed |